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 SUMMARY 
 
The PARPSso thermoprotein from Sulfolobus solfataricus has been 
identified as a PARP-like enzyme that cleaves -NAD+ to synthesize 
oligomers of ADP-ribose and cross-reacts with polyclonal anti-PARP-1 
catalytic site antibodies. Despite the biochemical properties that allow to 
correlate it to PARP enzymes, the N-terminal and partial amino acid 
sequence suggest the sulfolobal enzyme belongs to a different class of 
enzymes, the DING proteins. Considering the high sequence identity with 
the human DING protein HPBP and the lack of a nucleotide coding 
sequence in both human and sulfolobal genomes, we hypothesized that 
PARPSso might share other features with the human DING. Further 
analysis of PARPSso amino acid sequence addressed the research towards 
studying other possible similarities between human and sulfolobal protein 
and then to explain how PARPSso correlates with canonic PARPs. For 
the latter question, the peculiar behaviour of the thermozyme, that is 
biochemically, but not structurally related to the classic PARPs, 
stimulated to investigate by computational analysis and databank, whether 
the protein might be phylogenetically related to any already known PARP 
amino acid sequence. 
Moreover, immunochemical and enzymatic crossed analyses were 
performed to establish whether purified HPBP and PARPSso have 
common immunoreactive and functional behaviour. 
The second part of the research was focused on the localization of 
PARPSso within the sulfolobal cell. Our interest to this item arose from 
the property of some DING proteins to be membrane bound, suggested to 
work as membrane transporters. On the other hand, from previous studies, 
it is known that PARPSso is only partially solubilized from the starting 
cell homogenate provided by ICMIB (CNR), and the soluble enzyme is 
strictly associated with DNA. In this thesis work, whole cells collected by 
centrifugation from culture medium were subjected to a different 
extraction procedure. This procedure included also experimental 
conditions used to differentiate between soluble (i.e. cytoplasmic) and 
insoluble (i.e. membrane-bound) protein fractions. PARPSso and DNA 
distributions were determined by enzyme assay, immunoblotting and 
agarose gel electrophoresis. Reciprocal interactions of thermozyme, 
nucleic acid and membrane lipids were investigated with different 
techniques and methodologies (nucleoid preparation, fluorescence 
binding assays, fluorescence microscopy analysis). 
 
 RIASSUNTO 
 
La termoproteina PARPSso da Sulfolobus solfataricus è stata 
identificata come un enzima di tipo poli-ADP-ribosilante che utilizza -
NAD
+
 come substrato per sintetizzare oligomeri di ADP-ribosio, e 
reagisce con anticorpi policlonali anti-sito catalitico della PARP-1. 
Nonostante le proprietà biochimiche permettano di correlarla ad enzimi 
PARP, la parziale sequenza amminoacidica e la sequenza N-terminale 
indicano che l'enzima sulfolobale appartiene ad una diversa classe di 
enzimi, le proteine DING. Considerando l'elevata identità di sequenza con 
la proteina DING umana, HPBP, e la mancanza di una sequenza 
nucleotidica codificante in entrambi i genomi umano e sulfolobale, si ci è 
chiesti se PARPSso potesse condividere altre caratteristiche con la DING 
umana. Ulteriori analisi della sequenza amminoacidica della PARPSso 
hanno indirizzato la ricerca verso lo studio di altre possibili similitudini 
tra la proteina umana e sulfolobale, e successivamente a spiegare come la 
PARPSso si correli alle canoniche PARPs. In merito a quest’ultimo 
quesito, il peculiare comportamento del termozima, che è correlato dal 
punto di vista biochimico, ma non strutturale alle classiche PARP, ha 
spinto ad indagare, mediante analisi computazionale e in banca dati, se la 
proteina potesse essere filogeneticamente correlata alla sequenza di 
qualche già nota PARP. Inoltre sono state effettuate analisi 
immunochimiche ed enzimatiche incrociate per valutare se le proteine 
purificate HPBP e PARSso avessero un comportamento comune dal punto 
di vista immunochimico e funzionale. 
La seconda parte della ricerca si è concentrata sulla localizzazione della 
PARPSso nelle cellule sulfolobali. L’interesse verso questo aspetto è 
sorto considerando che alcune proteine DING sono legate a membrana, 
suggerendone un ruolo come trasportatori di membrana. D’altra parte, da 
studi precedenti, è noto che l’enzima PARPSso è solo parzialmente 
solubilizzato a partire dall’omogenato cellulare fornito dall’ICMIB 
(CNR), e che l’enzima solubile è strettamente associato al DNA. 
Nel presente lavoro di tesi, cellule intere di S. solfataricus, raccolte per 
centrifugazione a partire da una coltura cellulare, sono state sottoposte a 
una diversa procedura di estrazione. Tale procedura ha previsto anche 
condizioni sperimentali utilizzate per distinguere frazioni contenenti 
proteine solubili (es. citoplasmatiche) e insolubili (es. di membrana). 
La distribuzione della PARPSso e del DNA è stata determinata con saggi 
enzimatici ed analisi mediante immunoblotting e elettroforesi su gel 
d’agarosio. Le interazioni reciproche di termozima, acido nucleico e lipidi 
di membrana sono state studiate con diverse tecniche e metodologie 
 (preparazione del nucleoide, saggi di legame in fluorescenza, analisi di 
microscopia a fluorescenza). 
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INTRODUCTION 
 
1.1 The poly-ADP-ribosylation reaction and the PARP family 
In eukaryotic cells poly-ADP-ribosylation is a widespread post-
translational modification of proteins catalysed by a family of NAD
+
 
ADP-ribosyl transferases, the poly-ADP-ribose polymerases (PARPs) 
(Hassa et al., 2008). PARPs utilize NAD
+
 molecule as substrate to 
transfer successive ADP-ribose units to glutamic or aspartic acid residues 
of target proteins, giving rise to long and branched ADP-ribose polymers 
(Amé et al., 2004). 
 
The poly-ADP-ribosylation reaction can be divided in various phases: 
- break of  the N-glycosidic bond between nicotinamide and ribose, 
with release of the nicotinamide and attachment of the first 
adenosine diphosphate ribose unit (ADPR) to glutamic or aspartic 
acid residues via an ester linkage. 
- Elongation of the linear chain by 1’’→2’ ribose-ribose glycosidic 
bonds between ADPR units, (synthesis of a linear polymer, up to 
200 units). 
- Branching of the polymer every 20–50 units (Hayashi K. et al., 
1983), (Figure 1). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: Chemical structures of NAD
+
, nicotinamide (NAm) and 
poly ADP-ribose (PAR). The degradation of PAR is catalyzed by PARG, 
which has both exoglycosidase (PARG(a)) and endoglycosidase activity 
(PARG(b)). Remaining protein-proximal ADP-ribose is removed by 
ADP-ribosyl protein lyase. 
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The PARP family comprises 18 known members identified by homology 
searching and in silico characterization (Amé et al., 2004; Otto et al., 
2005), that share homology with the catalytic domain of the founding 
member, PARP-1. 
PARP-1 has a highly conserved structural and functional organization 
including  (Figure 2): 
 a N-terminal DNA-binding domain (DBD) with two zinc finger 
motifs (FI and FII) that act as “nick sensor” and recognise DNA 
damage (D’Amours et al., 1999) and a third one recently 
identified (Langelier et al., 2008), that mediates interdomain 
contacts important for DNA-dependent enzyme activation. Two 
helix-turn-helix motifs are also contained within the PARP-1 
DBD and are essential for its binding to DNA; 
 a nuclear localization signal (NLS) that targets PARP-1 to the 
nucleus (Schreiber et al., 1992); 
 a central auto-modification domain containing a BRCT motif as 
well as several glutamic acid residues for PAR binding 
(Desmarais et al., 1991). The BCRT domain mediates PARP-1 
homodimerisation and its interaction with other protein partners 
(heterodimerisation); 
 a C-terminal catalytic domain with a contiguous 50-amino-acid 
sequence, the “PARP signature” motif, that forms the active site.  
 
All the members belonging to the PARP family have different size, 
cellular localization and role: the most known PARP-1 and PARP-2, 
PARP-3, tankirase1, vPARP are localized in different subcellular sites, 
respectively nucleus, centrosomes, telomers and vaults particles in 
cytoplasm (Paul et al., 2005). Some of the recently discovered PARPs 
(PARP-6, PARP-16  and PARP-10) seem to be closer to ADP-ribosyl 
transferases, as they catalyze mono-ADP-ribosylation, (Kleine et al., 
2008). Hottiger et al. proposed a new nomenclature based on sequence 
and structure homology search of the conservative ADP-
ribosyltransferase fold (Figure 3), and enlarged the family of ADP-
ribosylating enzymes by including in it mono- and poly- ADP-
ribosylation proteins, and named all members as ARTs (Hottiger et al., 
2010). 
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Figure 2: Classical schematic representation of domain structures of 
the PARP family members.  
The meaning fo single domains is explained in Figure 3. 
 
 
 
 
 
Introduction 
4 
 
 
Figure 3: A new schematic comparison of the functional domains of the 
human ARTD (PARP) family. 
The most relevant are: ART, is the catalytic core required for basal ART 
activity. PARP regulatory domain (PRD) might be involved in regulation of the 
PARP-branching activity. WGR, characterized by the conserved central motif 
(W-G-R), is also found in a variety of polyA polymerases and in proteins of 
unknown function. BRCT domain (BRCA1 carboxy-terminal domain) is found 
within many DNA damage repair and cell cycle checkpoint proteins. Macro 
domain can serve as ADPr or O-acetyl-ADPribose binding module. ZF: zinc 
finger domains, recognizing DNA breaks (Hottiger et al., 2010). 
 
 
 
Only two out of the eighteen PARP family members are activated in 
response to DNA damage, PARP-1 and PARP-2 (Amé et al., 1999).  
The 113 kDa PARP-1 is the most abundant PARP enzyme found in living 
cells, with an average 1.0×10
6 
molecules per cell (Yamanaka et al., 1988; 
D’Amours et al., 1999), and accounts for at least 85% of the cell PARP 
activity (Shieh et al., 1998). both of them are activated for PAR polymer 
synthesis on binding to DNA strand breaks, and are involved in single-
strand break (SSB), double strand break (DS) and base excision (BE) 
repair. Cell PAR levels are increased up to 500-fold following DNA 
damage induction (Benjamin, R.C., Gill, D.M., 1980; Menissier-de 
Murcia et al., 1989). PARP binds to DNA containing single-strand breaks  
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as a homodimer resulting in its activation. One monomer is then able to 
auto-modify the other, leading to an accumulation of negative charge and 
causing repulsion of the dimer from the DNA (Ferro, A.M., Olivera, 
B.M., 1982; Woodhouse B. C., Dianov G. L., 2008) (Figure 4). This auto-
modification also inhibits both ADP-ribosyl transferase and protein–
protein interaction activities of PARP (D’Amours et al., 1999). 
 
 
 
 
Figure 4: Mechanism of action of PARP-1 in the presence of 
DNA strand breaks. 
 
 
Moreover the molecular mechanism of BER may involve a local 
chromatin relaxation mediated either by covalent modification of histones 
with poly-ADP-ribose or by non-covalent interaction of histones with 
poly-ADP-ribose that automodifies the enzyme. This regulates the  
accessibility to other DNA repair proteins. In addition PARP-1 has been 
shown to directly recruit repair protein like XRCC1 (X-ray repair cross-
complementing 1) to the site of DNA damage (El-Khamisy et al., 2003). 
 
The metabolism of PAR is a dynamic process involving also its 
degradation. In humans two genes have been identified whose products 
exhibit poly-ADP-ribose glycohydrolase (PARG) activity, namely PARG 
and more recently ARH3. The PARG gene encodes the predominant long 
nuclear/cytoplasmic isoform (~110 kDa) and, by alternative splicing, a 
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short catalytically active cytoplasmic isoform (~65 kDa), (Meyer-Ficca et 
al., 2004). Recently in mammals it has been reported the existence of a 
second 39 kDa protein, ARH3, exhibiting PARG-like activity (Oka et al., 
2006). Even if they are structurally unrelated, these enzymes hydrolyze 
the glycosidic bonds of PAR polymers to generate free ADP-ribose, 
leaving the protein-proximal ADP-ribose monomers to be removed by 
ADP-ribosyl protein lyase (Figure 1).  
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1.2 Sulfolobus solfataricus and the PARPSso enzyme 
Sulfolobus solfataricus belongs to Archaea which, together with 
Eukarya and Eubacteria kingdoms, represents the third domain of living 
organisms (Woese et al., 1990).  
Although present in several vulcanic areas, S. solfataricus was first 
isolated from an acidic hot spring in Agnano (Napoli, Italy). It is a 
thermophilic sulphur-dependent archaeon living optimally at 87 °C and 
pH 3.5 (De Rosa et al., 1975), even if it has a neutral cytoplasmic pH 
around 6.5-7.0.  
The particular biochemical composition of the membrane, including lipids 
with tetraethers bonds forming a monolayer (Gambacorta et al., 2004), 
confers them great impermeability and resistence to high temperature and 
extreme conditions (Limauro et al., 2004). 
The genome of the crenarchaeon Sulfolobus solfataricus P2 contains 
about 3x10
6
 bp on a single chromosome and putatively encodes 2977 
proteins. One-third of the encoded proteins have no detectable homologs 
in other sequenced genomes. Moreover, 40% appear to be archaeal-
specific, and only 12% and 2.3% are shared exclusively with bacteria and 
eukarya, respectively (She et al., 2001). Although the latter percentage 
seems to be very low, and Archaea are morphologically similar to 
eubacteria, it’s important to underline that the members of the genus 
Sulfolobus, possess trancription  and translation factors similar to those 
found in eukaryotes (Sutrave et al., 1994; Keeling, P.J., Doolittle, W.F., 
1995). 
 
In the laboratory where the research project of this thesis has been carried 
out, a poly-ADP-ribose polymerase (PARP)-like thermoprotein, 
PARPSso, was found in Sulfolobus solfataricus (Faraone-Mennella et al., 
1998), representing the first evidence of an ADP-ribosylation activity in 
Archaea.  
Scheme 1 shows the main properties of PARPSso and differences from  
human PARP-1 (116kDa): lower molecular mass (46.5kDa) and 
isoelectric point (pH 7.0-7.2), and high thermophily (80°C). The 
thermozyme  cleaves -NAD+ to synthesize short ADP-ribose oligomers 
(5-6 units) and cross-reacts with both polyclonal anti-PARP-1 catalytic 
site and anti-poly-ADP-ribose polymerase antibodies, but not with anti-
DNA-binding PARP-1-N-terminus antibodies (Faraone-Mennella et al., 
1998). Similarly to eukaryotic PARP-1, PARPSso is activated by and 
binds DNA with high affinity and non-specifically (Faraone-Mennella et 
al., 2002), modifies itself (automodification) and a 7kDa protein (Sso7) 
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(heteromodification)  that binds and condenses archaeal DNA (Faraone-
Mennella et al., 1995; Castellano et al., 2009). 
 
 
Scheme 1: Biochemical features of PARPSso and PARP-1 
 
PARPSso PARP-1 
Size 46.5 kDa 116 kDa 
Optimum 
temperature 
80°C 25°C 
Isoelectric point 7.1 9.5 
KM NAD 15050 M 20-80 M 
Activators Mg
2+
 Mg
2+
 
3-ABA inhibition 50% 100% 
ADPR chain length 
4-5 
residues 
Up to 200 
residues 
Anti-PARP 
immunoreactivity 
+ + 
DNA binding 
ability 
+ + 
Automodification + + 
Heteromodification + + 
 
 
 
Although PARPSso has been characterized biochemically, in the whole 
genome of S. solfataricus (strain P2) no gene sequence has been found, 
corresponding to classic PARPs.  
Recently the partial amino acid sequence of  PARPSso clearly indicated 
that the analysed PARPSso N-terminus and tryptic peptides (about 60% 
of total residues) do not share structural similarity with any of known 
PARPs, but the peculiar feature of N-terminus (40 residues) overlaps 
those of DING proteins, as shown in the alignment of Figure 5 (Di Maro 
et al., 2009).  This is the first example of a DING protein from Sulfolobus 
solfataricus and, in general from Archaea. 
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Figure 5: Partial amino acid sequence of PARPSso (in bold font). 
A multiple alignment between PARPSso, DING proteins from Pseudomonas 
fluorescence (ZP_00138283), human (2CAP_A), and plant Hypericum 
perforatum (p27SJ) is shown. Identical residues (*), conserved substitutions (:) 
and semi-conserved substitutions (.) are reported. The conserved residues 
involved in phosphate-binding site in DING proteins are also indicated (©). 
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1.3 DING proteins 
The DING proteins (38–40 kDa) are ubiquitous proteins, 
characterized by a conserved N-terminal sequence, DINGGG (Berna et 
al., 2009). In 1990s they were first identified in several animal and plant 
tissues, and then in most eukaryotes and a range of bacterial organisms 
(Berna et al., 2002). At present the DING family includes about 30 
members. 
DING proteins are usually secreted, although some are sometimes found 
in the cytosol (Luecke et al., 1990; Berna et al., 2002). Their roles are not 
completely clearied yet; however the ability to bind phosphate seems to 
be a common property, confirmed by three-dimensional structure analysis 
of both eukaryotic and prokaryotic DING proteins (Berna et al., 2009). 
Except for one prokaryotic DING protein, no complete gene sequences 
have been identified in all the eukaryotic genome databases. 
 
 
1.3.1 DING proteins in Prokaryotes 
In prokaryotes DING proteins are part of a superfamily of 
phosphate-binding proteins that comprises three sub-groups, based on 
sequence similarities and functions: 
1. ubiquitous membrane-bound or periplasmic Psts proteins that 
participate in phosphate uptake and belong to transmembrane 
ABC transporters. These periplasmic proteins haven’t the 
characteristic N-term sequence, but show 20-25% identity with the 
eukaryotic DING proteins;  
2. some low relative molecular weight (Mr) alkaline phosphatases 
only described in Pseudomonas; 
3. true bacterial DING proteins that share around 70-80% identity 
with the eukaryotic ones (Berna et al., 2008). 
The gene for one such protein, PfluDING from P. fluorescens SBW25, 
has been cloned and expressed in Escherichia coli (Scott K, Wu L., 
2005). It binds a single phosphate ion, but has no detectable phosphatase 
activity. It is an extracellular protein, which expression is linked to low 
extracellular phosphate levels. This suggests that PfluDING could be 
involved in extracellular scavenging of phosphates, which are 
subsequently taken up by the cell-bound Pst transport system (Zhang et 
al., 2007). PstS and DING proteins co-exist in some Pseudomonas 
strains, which they confer a highly adhesive and virulent phenotype to.  
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Recently in the thermophilic bacterium Thermus thermophilus it has been 
identified a phosphatase with a tipical DING N-terminal sequence that 
interacts with the cell membrane. It has a molecular weight of 40 kDa, 
and  exhibits optimal phosphatase activity at pH 12.3 and 70 °C. This 
DING protein is a multifunctional enzyme with ATPase, endonuclease 
and 3’-phosphodiesterase activities; moreover it binds to linear dsDNA, 
displaying helicase activities and could thus be involved in DNA repair 
(Pantazaki et al., 2008). 
 
 
1.3.2 DING proteins in Eukaryotes 
In eukaryotes DING proteins have been identified in animals 
(human, monkey, rat, turkey), plants (Hypericum perforatum, Arabidopsis 
thaliana, potato, tobacco) and fungi (Candida albicans, Ganoderma 
lucidum) (Berna et al., 2008; Darbinian-Sarkissian et al., 2006) mostly as 
a 40 kDa protein or higher molecular weight DING proteins (Perera et al., 
2008). In particular in mice, DING proteins are present as isoforms of 
various molecular weights. Their intracellular localization is tissue-
dependent, being exclusively nuclear in neurons, but both cytoplasmic 
and nuclear in other tissues (Collombet et al., 2010). 
Some of these proteins seem to have key roles in various human diseases, 
e.g., rheumatoid arthritis, atherosclerosis, HIV suppression. Although this 
protein family seems to be ubiquitous in eukaryotes, their genes are 
consistently lacking from genomic databases (Berna et al., 2009). 
The only eukaryotic DING protein with a complete amino acid sequence 
is HPBP, the Human Phosphate Binding Protein. It is a serendipitously 
discovered plasma apolipoprotein that binds phosphate and is isolated 
from human plasma (Contreras-Martel et al., 2006). It forms hetero-
oligomers that stabilize paraoxonase (PON1), a plasma enzyme known 
for its anti-atherogenic properties (Shih et al., 1998); HPBP could thus be 
indirectly involved in protection against atherosclerosis (Rochu et al., 
2007; Rochu et al.,  2008). 
HPBP structure was solved (Morales et al., 2006) and it has confirmed 
the structural homology with bacterial PstS one; it corresponds to a 
“Venus flytrap” model, in which two globular domains hinge together to  
create a phosphate-binding site between them, comprising the eight well 
conserved amino acid residues (Berna et al., 2008). 
Three other human DING proteins involve the crystal adhesion inhibitor 
(CAI), the human synovial stimulatory protein (SSP), and the X-DING-
CD4
+
 from human CD4
+
 T lymphocytes (Lesner et al., 2009). 
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Although the amount of data concerning this protein family has increased 
over the last few years, their physiological functions remain largely 
unknown, and their origin in eukaryotes is still under debate (Berna et al., 
2009). 
 
 
 
 
1.3.3 DING proteins in Archaea 
The recent partial amino acid sequence of PARPSso clearly 
indicated that the sulfolobal thermozyme is a DING protein. The 
thermostable poly-ADP-ribose polymerase-like enzyme from Sulfolobus 
solfataricus has the characteristic DING N-terminal sequence and 
represents the first example of the archaeal DING protein; this finding 
extends the existence of DING proteins to the third kingdom of life (Di 
Maro et al., 2009). 
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1.4 Scientific hypothesis and aim of the work 
The PARPSso thermoprotein from Sulfolobus solfataricus has been 
identified as a PARP-like enzyme that cleaves -NAD+ to synthesize 
oligomers of ADP-ribose and cross-reacts with polyclonal anti-PARP-1 
catalytic site antibodies. 
Despite the biochemical properties that allow to correlate it to PARP 
enzymes, the N-terminal and partial amino acid sequence suggest the 
sulfolobal enzyme belongs to a different class of enzymes, the DING 
proteins. 
Considering the high sequence identity with the human DING protein  
HPBP and the lack of a nucleotide coding sequence in both human and 
sulfolobal genomes, we hypothesized that PARPSso might share other 
features with the human DING. Further analysis of PARPSso amino acid 
sequence, addressed the research towards studying other possible 
similarities between human and sulfolobal protein, then to explain how 
PARPSso correlates with canonic PARPs. For the latter question, the 
peculiar behaviour of the thermozyme, that is biochemically, but not 
structurally related to the classic PARPs, stimulated to investigate by 
computational analysis and databank, whether the protein might be 
phylogenetically related to any already known PARP aa sequence. 
Moreover, immunochemical and enzymatic crossed analyses were 
performed to establish whether purified HPBP and PARPSso have 
common immunoreactive and functional behaviour. 
The second part of the research was focused on the localization of 
PARPSso within the sulfolobal cell. Our interest to this item arose from 
the property of some DING proteins to be membrane bound, suggested to 
work as membrane transporters. On the other hand, from previous studies, 
it is known that PARPSso is only partially solubilized from the starting 
cell homogenate provided by ICMIB (CNR), and the soluble enzyme is 
strictly associated with DNA. In this thesis work, whole cells collected by 
centrifugation from culture medium were subjected to a different 
extraction procedure. This procedure included also experimental 
conditions used to differentiate between soluble (i.e. cytoplasmic) and 
insoluble (i.e. membrane-bound) protein fractions. PARPSso and DNA 
distribution were determined by enzyme assay, immunoblotting and 
agarose gel electrophoresis. Reciprocal interactions of thermozyme, 
nucleic acid and membrane lipids were investigated with different  
techniques and methodologies (nucleoid preparation, fluorescence 
binding assays, fluorescence microscopy analysis). 
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MATERIALS AND METHODS  
 
2.1 Materials 
 Nicotinamide adenine dinucleotide di(triethylammonium)salt 
(adenylate-
32
P), [
32
P]NAD
+
, 1000 Ci/mmol, was supplied by GE 
Healthcare Europe GmbH, Bio-Sciences; DNase I (EC 3.1.21.1), 
phenylmethyl sulphonyl fluoride (PMSF), phosphatase substrate were 
obtained from SIGMA Chemical Company (Milan, Italy). Electrophoretic 
markers were purchased from BioRad (Milan, Italy). 
 
 
2.2 Human and sulfolobal protein crude extracts and DING proteins 
purification 
S. solfataricus (strain MT-4, DSM No. 5833) cells were grown at 
87°C (pH 3.5) and the crude homogenate was prepared from the collected 
cells as described in Faraone Mennella et al., 1998. All protein solutions 
contained a cocktail of protease inhibitors (2 g/ml). PARPSso was 
purified by a two-step chromatographic protocol starting from a crude 
extract obtained digesting the crude homogenate with DNase I (Faraone 
Mennella et al., 1998). Protein concentration was determined by Bradford 
protein assay.  
For PARPSso analysis from sulfolobal cells, grown on yeast (Y) and 
glucose (G) medium, at exponential (E) and stationary (S) phase, 1 
O.D.600 of each culture was centrifuged at 6000 rpm for 20 min and the 
pellet suspended with assay buffer (100 l; § 2.7); aliquots (10 l) were 
used for enzymatic assay and SDS-PAGE analysis. 
Human sera were provided by the transfusional centre of the Hospital 
“Agostino Maresca” in Torre del Greco (Naples, Italy). 
Purifed DING protein HPBP was provided by Chabriere’s group 
(Marseille Universite´, Marseille, France; Contreras-Martel et al., 2006). 
 
 
2.3 SDS-PAGE and immunoblotting 
Proteins were analyzed on 12% polyacrylamide slab gels in the 
buffer system Tris-Glycine in the presence of 0.1% SDS as described 
previously (Faraone Mennella et al., 1998) and electrotransferred onto 
PolyVinyliDene Fluoride (PVDF) membrane (Bio Rad) at 200 mA for 2 
hours at 4°C in the same buffer used for the electrophoretic run with 
0.025% SDS. 
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Staining was in 0.1% Coomassie R-250, in 10% acetic acid and 45% 
methanol. Gels were destained in 10% acetic acid and 10% ethanol 
solution.  
Silver staining was performed according to procedure described in  
Rabilloud, T., 1992. 
Images of stained gels, filters and autoradiographic patterns were 
acquired by a phosphor imager (mod. FX, Bio-Rad). 
For immunoblot experiments, procedures and buffers were as previously 
described (Faraone Mennella et al., 1998). PVDF sheets were treated for 
1.5 hr with the blocking solution, TBST (50 mM Tris-HCl, pH 8.0, 150 
mM NaCl, 0.5 % (v/v) Tween 20), and 3 % (w/v) gelatine. Incubation 
with primary antibody (used antibodies are listed in Table 1) was 
performed for 2 hr at room temperature in the same solution 
supplemented with 0.3 % gelatine. 
The blots were then washed several times with TBST buffer and antibody 
binding was detected by using horseradish peroxidase (HRP)-conjugated  
secondary antibody, specific for each primary antibody, after incubation 
for 1 hr at room temperature. HRP reaction was revealed by using a kit 
for chemiluminescence (Super Signal West Dura Extended Substrate, 
34075, PIERCE) and measured by the phosphor imager (BioRad). 
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TABLE 1: Main characteristics of specific anti-PARP and anti-DING 
proteins antibodies. 
Dilution and secondary antibodies (AbII) used are also indicated. 
 
 
 
A stripping procedure was used to remove antibodies from the western 
blot membranes, to allow  incubation with  other antibodies. Stripping 
buffer contained 62.5 mM Tris-HCl (pH 6.8), 2% SDS and a final 
concentration of 0.1 M 2-mercaptoethanol. The filter was washed in 
TBST (3 x 5 min) and incubated in stripping buffer for 1h and 50 min at 
60°C (in a heating oven). Washes in TBS (5 x 10 min) followed and the 
membrane was blocked for 1.5 h in TBST/3% gelatine. The filter was 
used for developing the next immunoblot. 
 
 
2.4 Alkaline filter treatment 
To detache PAR from the protein immobilized on PVDF 
membrane, after the stripping procedure, the filter was incubated 
overnight  in 20 mM Tris/HCl pH 8.0 at 4°C. Then it was washed in 
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TBST buffer (3 x 5 min) and incubated again for immunoblot with anti-
PAR antibodies. 
 
 
2.5 Protein sequencing by mass spectrometry  
 
2.5.1 Electrophoresis fractionation and in situ digestion 
The protein mixture was fractionated by gel electrophoresis. 
Selected protein bands stained by Colloidal Comassie were excised from 
the gel and washed in 50 mM ammonium bicarbonate pH 8.0 in 50% 
acetonitrile to a complete destaining. The gel pieces were re-suspended in 
50mM ammonium bicarbonate pH 8.0 containing 100 ng of trypsin and 
incubated for 2 hr at 4°C and overnight at 37°C. The supernatant 
containing the resulting peptide mixtures was removed and the gel pieces 
were re-extracted with acetonitrile. The two fractions were then collected 
and freeze-dried. 
 
2.5.2 MALDI MS and MALDI MSMS analysis 
MALDI mass spectra were recorded on an Applied Biosystem 
4800 plus MALDI TOF-TOF Analyzer mass spectrometer equipped with 
a reflectron analyser and used in delayed extraction mode with 4000 
Series Explorer v3.5 software. Aliquot of 0.5l of peptide sample was 
mixed with an equal volume of -cyano-4-hydroxycynnamic acid as 
matrix (10 mg/ml in 0.2% TFA in 70% acetonitrile), applied to the 
metallic sample plate and air dried. Mass calibration was performed by 
using the standard mixture provided by manufacturer 
MALDI-MS data was acquired manually over a mass range of 600–
5000 Da in the positive-ion reflector mode. In each MS spectrum, specific 
MS peaks were selected for manual MS/MS analysis, using a 1 kV 
MS/MS operating mode.  
 
2.5.3 LCMSMS analysis 
The aliquot of peptide mixtures were further analyzed by 
LCMSMS using a LCMSMS using the LC/MSD Trap XCT Ultra 
(Agilent Technologies, Palo Alto, CA) equipped with a 1100 HPLC 
system and a chip cube (Agilent Technologies). After loading, the peptide 
mixture (8 l in 0.5% TFA) was first concentrated at 4 l/min in 40 nl 
enrichment column (Agilent Technologies chip), with 0.1% formic acid 
as the eluent. The sample was then fractionated on a C18 reverse-phase 
capillary column (75 µm x 43 mm in the Agilent Technologies chip) at a 
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flow rate of 300 nl/min, with a linear gradient of eluent B (0.1% formic 
acid in acetonitrile) in A (0.1% formic acid) from 7 to 50% in 35 min. 
Elution was monitored on the mass spectrometers without any splitting 
device. Peptide analysis was performed using data-dependent acquisition 
of one MS scan (m/z range from 400 to 2000 Da/e) followed by MS/MS 
scans of the three most abundant ions in each MS scan. Dynamic 
exclusion was used to acquire a more complete survey of the peptides by 
automatic recognition and temporary exclusion (2 min) of ions from 
which definitive mass spectral data had previously been acquired. 
Moreover a permanent exclusion list of the most frequent peptide 
contaminants (keratins and trypsin peptides) was included in the 
acquisition method in order to focus the analyses of significant data. 
 
 
2.6 Computational analysis 
In this study we performed a BLAST search of PARPSso sequence,  
on the web site http://blast.ncbi.nlm.nih.gov. We first searched all 
database with no “Entrez query” limit, and then we search a subset of the 
selected BLAST database for specific PARP domains and proteins 
(Figure 2-3). We used “blastp” algorithm with default general parameters. 
 
 
2.7 Enzyme assays 
ADP-ribosylating activity of crude and purified PARPSso was 
assayed at 80°C in the presence of 0.64 mM [
32
P]NAD
+ 
(10000 
cpm/nmol) according to Faraone Mennella et al., 1998. Automodification 
reaction was monitored by precipitating proteins from the reaction 
mixture (62.5 l) with ice-cold 20% TCA, freed of NAD+ with several 
10% TCA washes, and the radioactivity present in the acid-insoluble 
material, was collected on a HAWP (0.45 m, Millipore) filter and 
determined on a Beckman LS 1701 liquid scintillation spectrometer. One 
enzymatic unit was defined as the amount of enzyme catalyzing the 
incorporation, per min at 80°C, of 1 mol of ADP-ribose into acid-
insoluble material. Human sera and pure HPBP were assayed for 
mesophilic PARP activity at 25°C as previously described in Faraone 
Mennella et al., 2003. 
Alkaline phosphatase activity was assayed by monitoring the release of p-
nitrophenol by hydrolysis of p-nitrophenyl phosphate (Pantazaki et al., 
2008). The reaction mixture consisted of 1 mM p-nitrophenyl phosphate 
and 50 mM KCl–NaOH buffer pH 12.3 in a final volume of 1 ml. The 
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reaction was initiated by adding 5 l of sample preparation and the 
mixture was incubated at 70 °C (Sulfolobus proteins) or  37°C (human 
proteins). The reaction was followed by monitoring the absorbance 
increase at 405 nm. One enzyme unit represents the amount of enzyme 
hydrolysing 1 mol of substrate per min under the aforementioned 
conditions. 
As negative control the absorbance increase of a reaction mixture without 
enzymes was also measured. A commercial alkaline phosphatase from 
human placenta (type XXIV, Sigma-Aldrich, Milan, Italy) was the 
positive control. 
 
 
2.8 Agarose gel electrophoresis 
The fraction derived from the different extraction procedures were 
suspended in Loading Dye Solution (MBI Fermentas) and loaded on 1% 
agarose gel in TAE buffer (40 mM Tris, 0,1% Acetic acid, 1 mM EDTA), 
electrophoresed  at 100 V , stained with 0.5 μg/ml of ethidium bromide 
and visualized in a UV transilluminator. 
 
 
2.9 Fluorescence anisotropy 
Fluorescence experiments were performed in Dr. Sandra Greive’s 
lab (John Innes Centre, Norwich, UK). DNA oligonucleotides were  
chemically synthesized and purified by high pressure liquid 
chromatography (Integrated DNA Technologies, GB). The 45 bp oligo 
(“oligo ss-a”), tagged at 5’end with the fluorescent dye 5-6FAM, had the 
sequence 5'- /56-FAM/AT TTT AGC TAG TCG ACG TGG TCC ATA 
ATG CTT AAT CCC AAA TTA T -3'. The unlabeled oligo is shorter 
(half) than the tagged one and complement it starting from 3’-end               
(5'- ATA ATT TGG GAT TAA GCA TTA TGG ACC ACG TCG ACT 
AGC TAA AAT -3'). The mixture of the two oligos is indicated as “oligo 
ds-b”. The anisotropy measurements were done with a LS 55 
Fluorescence Spectrometer (Perkin Elmer) equipped with a Peltier cooler 
to control the sample temperature, in Sub-micro low head space cuvette 
(Starna) in a total volume of 13 l, at 40 °C. Excitation  and emission 
parameters were setted at 480 and 525 nm, respectively. Each oligo (50 
nM) was titrated with PARPSso in assay buffer (10 mM sodium 
phosphate, 5 mM EDTA, pH 8.0). 
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Anisotropy data were fitted to a “Ligand binding-1site” equation by using 
GraFit program. In the graphs the reported A values (Ax-A0) were 
obtained from the difference of anisotropy values in the presence (Ax) and 
in the absence (A0) of increasing PARPSso. 
 
 
2.10 Nucleoid preparation 
Nucleoid from S. solfataricus cells was isolated by a procedure 
described for S. acidocaldarius (Reddy T.R. and Suryanarayana T., 1989) 
with some modifications. Harvested cells (0.3 g) were suspended in 10 
mM Tris-HCl, pH 7.5, 100 mM NaCl (1 ml) and were lysed by the 
addition of 10 mM Tris-HCl, pH 7.5, containing 1% Nonidet P-40, 2 mM 
spermindine-HCl, 10 mM Na2EDTA (1 ml), cocktail of protease 
inhibitors (2g/ml), 1 mM PMSF and incubated at 10 °C for 30 min. The 
lysate was centrifuged at 1000xg for 5 min. The clear viscous lysate was 
dissolved in 5% saccarose and layered on 15-50% discontinuous gradient 
in 10 mM Tris-HCl, pH 7.5, 3 mM MgCl2, 1 mM PMSF and centrifuged 
at 10000xg for 16 hours. The gradient was fractioned by collecting 1 ml 
fractions from the top, dialyzed against water and analysed by SDS-
PAGE and on agarose gel. Protein content was estimated by Bradford 
protein assay. Absorbance at 260 and 280 nm of the gradient fraction was 
also measured. 
 
 
2.11 Lipid extraction and Thin Layer Chromatography (TLC) 
For the detection of lipids, some main gradient fractions were 
subjected to lipid extraction  according to Bligh, E. G., Dyer, W. J., 1959. 
Fractions (150 l) were incubated with methanol (600 l) and chloroform 
(300 l) for 30 min at 37 °C. Then 420 l water and 300 l chloroform  
were added and the mixture was vortexed for 10 min  at room temperature 
to mix the phases and centrifuged for 2 min at 2000xg for phase 
separation. The aqueous phase was removed. The lower chloroform phase 
was then completely evaporated and the lyophilized material was 
dissolved in chloroform/methanol (2:1, v/v; 10 l) and loaded on TLC, 
silica gel plate (Merck chemicals, Milan, Italy). The system was eluted 
with chloroform/methanol/water (65:25:4, v/v). Staining with 0.5% 
Amido black 10B (Sigma Aldrich, Milan, Italy) in 1 M NaCl and 20% 
ethanol allowed to reveal lipids as blue spots (Plekhanov, A. Y., 1999). 
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2.12 Immunofluorescence microscopy 
Fresh log-phase sulfolobal cells were fixed with 10% methanol and 
then, for cell wall permeabilization, they were suspended in 10 mM 
Tris/HCl pH 8.0 and incubated with proteinase K (20 g/ml) at room 
temperature for 10 min according to some indications described in Teira 
et al., 2004. For immunofluorescence microscopy, permeabilized cells 
were suspended in PBS-2% BSA and incubated with anti PARP-1 Ab 
(Santa Cruz; 1:50) overnight at 4 °C. After washing with PBS, cells were 
incubated with the secondary antibody (Alexa Fluor 488 goat anti-rabbit 
IgG; Invitrogen, 1:200 in PBS) for 1 h, and finally washed in PBS. 
Human A375 melanoma cells were fixed with 4% formaldehyde, 
permeabilized with 0.5% triton, and analysed in the same way. 
Live cells were stained with 4′,6′-diamidino-2-phenylindole (DAPI) (0.2 
μg/ml; Molecular Probes) and FM 64 (5 μg/ml; Molecular Probes) for 
DNA and membrane detection, respectively (Sharp, M. D., Pogliano, K., 
1999). 
Microscopy images were carried out with an Olympus BX51 microscope 
with 100x UPlanF1and U-WIBA filter. Images were captured by 
analySIS software (SIS).  
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RESULTS 
 
3.1 PARPSso and DING proteins 
 
3.1.1 PARPSso amino acid sequence 
The partial N-terminus amino acid sequence and some tryptic 
peptides of the homogeneous archaeal thermozyme showed that the N-
terminus of PARPSso presents DINGGGATL, which is characteristic of 
DING proteins (Di Maro et al., 2009). 
We performed by mass spectrometry a further analysis of the purified 
PARPSso after separation on SDS-PAGE and digestion with trypsin of 
the Coomassie-stained protein band (Figure 6). 
 
 
 
Figure 6: SDS-PAGE (12%) of purified PARPSso.  
Lane 1: Marker  proteins; lane 2: PARPSso (1.2 g ). 
 
 
MALDIMSMS and LCMSMS analyses confirmed the previously 
sequenced regions and let to identify other peptides that align with DING 
protein sequences (human HPBP, 2CAP_A, and bacterial PfluDING),  
Figure 7. 
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MH
+
(mi)  
(MALDIMS) 
Parent ion 
(LCESIMSMS) 
PEPTIDE SEQUENCES 
(MALDI/MSMS and/or  
LC-ESI/MSMS)  
Aminoacid  
number range 
592.3  FLNAK 154-158 
613.3  AFFTK 319-323 
699.3  QPTWGK (con Gln->pyro-Glu) 78-83 
716.3  QPTWGK 78-83 
821.4  FVAGVSNK 47-54 
1005.6 503.3 TGPITVVYR 133-141 
1100.5  NVHWAGSDSK 55-64 
1115.6  FVPLPDNWK 340-348 
1143.5 572.3 AAFLTNDYTK 37-46 
1171.6 586.4 DINGGGATLPQK 1-12 
1201.6 601.6 TNVCcamDGI/LGRPI/L 367-377 
1219.6  ITDWSGISGAGR 121-132 
1314.6 657.9 SESSGTTELFTR 142-153 
1412.7 707.0 LTATELSTYATNK 65-77 
1521.01 761.1 GVMDAVNDTSVAEGR 194-208 
1698.0  LIQVPSVATSVAIPFR 84-99 
1736.9 868.6 SKGVMDAVNDTSVAEGR 192-208 
1774.7  HFGDTNNNDDAITANR 324-339 
1795.9 898.7 XXX(TD)NFVTASSALSIGK 349-366 
1826.1 913.7 LIQVPSVATSVAIPFRK 84-100 
2024.9 1013.2 SGANAVDLSVSELCcamGVFSGR 101-120 
2111.0   65-83 
2153.0  KSGANAVDLSVSELCGVFSGR 100-120 
2188.0 1094.7 ITYMSPDFAASTLAGLDDATK 209-229 
2204.0 1102.8 ITYMoxSPDFAASTLAGLDDATK 209-229 
2358.2 1180.0 LYQTSGVLTAGFAPYIGVGSGNGK 13-36 
2379.1   
78-99 
 (con Gln->pyro-Glu) 
2395.1   78-99 
2514.3   209-232 
 
Figure 7: MALDIMS (column one), and LC-ESIMSMS (column two) analyses. 
The sequences obtained by both analyses are reported in the third column. 
 
Results 
24 
 
 
Figure 8 shows the sequence obtained by integrating previous results (Di 
Maro et al., 2009) with the new ones obtained by mass spectrometry, 
aligned with the sequences of other DING proteins.  
 
 
 
Figure 8: Multialignment of PARPSso, HPBP (2CAP_A), and PfluDING by 
ClustalW program. The newly sequenced peptides are labeled in yellow. The 
conserved residues involved in phosphate-binding site in DING proteins are 
indicated (§). 
 
 
At present 80% sequence of the sulfolobal protein is known with a fairly 
90% similarity with DING proteins; the eight residues involved in 
phosphate-binding site of all DING proteins are conserved in PARPSso 
sequence too.  
BLAST search of PARPSso sequence, integrated in the lacking peptides 
with those of HPBP sequence, with no “Entrez Query” limit, as expected, 
gave a list of DING and P-binding proteins with different scores and E-
value depending on similarity percentages. This list did not include any 
PARP- or ADPRT- like sequence. 
We performed a different BLAST search by indicating singularly as 
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“Entrez Query” key words related to PARP peculiar domains, namely 
PARP signature, macrodomain, WGR-, PAR binding domains, or  single 
known PARP sequences from PARP1 to PARP18 (Figure 9).  
This search was made in parallel for PARPSso, HPBP, PfluDING with 
similar results. Figure 9 shows the results for PARPSso. Regions aligning 
with thermozyme are reported as a line that covers the corresponding 
DING sequence.  
 
 
Figure 9: Blast results of “Entrez query” with PARP-related key words. 
PARPSso sequence is indicated as black line on the top; numbers correspond to 
amino acid residues. Lines represent the PARP proteins regions aligning with 
PARPSso. Accession number and amino acids aligned length of the protein 
resulting from the BLAST search are also reported. The domains are those of 
Figures 2-3. 
 
 
Some amino acid motifs of PARP proteins matched with PARPSso; 
several similarities were along the whole sequences and extended to 
different tipical PARP domains (catalytic domain, WGR, PAR binding 
and NAD binding domain, macrodomain). 
A search for NAD-binding site was also performed among a series of 
resulting NAD dehydrogenases from different species; the two most 
significant ones were selected and shown in the Figure 9. It is worth 
noting  that, despite the low similarity of aligned peptides, all derived 
PARP sequences were localized in correspondence of PARPSso region 
spanning from about amino acid 100 to 300 (Figure 9). 
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3.1.2 Immunodetection of HPBP and PARPSso with different 
antibodies 
Considering the high structural similarity of PARPSso with DING 
proteins, we performed immunoblotting analysis of the two purified 
proteins, PARPSso and the human DING HPBP, with specific anti-PARP 
and anti-DING antibodies. DING proteins and antibodies were kindly 
provided by Ken Scott, New Zealand, and Eric Chabriere, France. 
In Coomassie stained gel (Figure 10A)  both HPBP (lane 1) and PARPSso 
(lane 4) appeared highly purified  with a single band at 38 kDa and >40 
kDa respectively, compared to the starting samples, human serum (lane 2) 
and sulfolobal homogenate (lane 3). 
 
 
 
Figure 10: A) 12% SDS-PAGE of HPBP, lane 1; human serum, lane 2; 
sulfolobal homogenate, lane 3;  purified PARPSso, lane 4. Coomassie staining. 
B) Immunoblotting with anti-PARP-CS Abs. 
C) Silver staining of lanes 1 and 4 of  gel in A.  
D) Immunoblotting with anti-DING-Nterm Abs, after stripping of filter in B. 
E) Immunoblotting with anti-PfluDING Abs, after stripping of filter in D. 
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Their immunoblotting with commercial anti-PARP-CS Abs showed the 
same strong  immunosignal between 55kDa and 98 kDa standard proteins 
(Figure 10B). This band was also evident in human serum (lane 2) and 
sulfolobal homogenate (lane 3). A second positive band corresponding to 
55kDa was present in the human serum (lane 2). Much less intense was 
the immunoband at 38kDa-40kDa for all samples. Feeble bands above 
117kDa were detected in all samples; a weak but net signal at 29 kDa was 
present in human serum (lane 2). For pure HPBP and PARPSso (Figure 
10A, lanes 1 and 4) silver staining of Coomassie-destained gel showed 
the presence in traces of bands corresponding to immunosignals between 
55kDa and 98 kDa standard proteins (Figure 10C, lanes 1 and 4). 
After stripping of the filter in Figure 10B and immunodetection with 
polyclonal anti DING-N-term Abs, a single, intense immunoband was 
localised only at about 40kDa, in correspondence of Coomassie stained  
pure  HPBP and PARPSso  (Figure 10D, lanes 1, 4). It corresponded to 
the faint component identified by anti-PARP-CS Abs. No signals were 
present in serum and sulfolobal supernatant (Figure 10D, lanes 2, 3). 
The filter was further stripped and incubated with polyclonal anti- Pflu 
DING (Figure 10B), and purified HPBP and PARPSso responded as in 
Figure 10E (lanes 1, 4). In serum and sulfolobal homogenate only the 70 
kDa signal appears at different intensities (Figure 10E, lines 2-3). 
 
In a second experiment of SDS-PAGE and western blotting, both crude 
extracts (human sera, sulfolobal homogenate) and purified proteins 
(HPBP, PARPSso) were analysed, by using anti-HPBP monoclonal and 
polyclonal antibodies. 
As expected HPBP reacted with both monoclonal antibodies, giving an 
intense band at 40 kDa (Figure 11A, lane 1); a faint signal is present only 
for PARPSso (Figure 11A, lane 2) and for human serum (Figure 11A, 
lane 4). After further stripping and polyclonal anti-HPBPpoliC 
immunoblotting, both the purified proteins (HPBP and PARPSso) reacted 
with a net signal close to 40kDa (Figure 11C, lanes 1, 2).  
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Figure 11: Immunoblotting analyses with monoclonal and policlonal anti-
HPBP Abs, and with anti-PAR Abs. 
Lane 1: HPBP; lane 2: PARPSso; lane 3: sulfolobal homogenate; lane 4: human 
serum. Immunoblotting with:  
A) monoclonal anti-HPBP 4D7 Abs. 
B) monoclonal anti-HPBP 8H6 Abs, after stripping of filter in A. 
C) policlonal anti-HPBP poliC, after stripping of filter in B. 
D) anti-PAR Abs, after stripping of filter in C. 
E) anti-PAR Abs, after stripping and alkaline incubation of filter in D. 
 
 
3.1.3 Cross-reactivity of HPBP and PARPSso with anti-PAR 
antibodies 
Due the occurrence in S. solfataricus of endogenously automodified 
PARPSso, that can be detected by immunoblotting with anti-PAR 
antibodies, the filter of  Figure 11C was stripped again and analysed with 
anti-PAR polyclonal antibodies. Beside the two purified proteins, 
showing an immunoprofile overlapping that of Figure 11C, in the lane of 
serum two immunosignal between 55kDa and 98 kDa appeared (Figure 
11D, lane 4). The slow migrating band was predominant. 
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In order to get evidence that the immunosignal with anti-PAR could be 
due to the presence of authentic poly-ADP-ribose, the stripped filter  was 
incubated overnight under alkaline conditions. Alkaline medium detaches 
PAR from acceptor proteins, converting the latter in the unmodified form. 
Alkali-incubated filter was re-analysed with anti-PAR antibodies. The 
signals of Figure 11D were weakned, indicating that alkali had removed 
some bound poly-ADP-ribose (Figure 11E). 
 
 
3.1.4 Enzymatic activities of HPBP and PARPSso 
The two purified proteins were assayed for ADP-ribosylating 
activity and gave the results reported in Table 2. PARPSso was about 35 
times more active than HPBP. Neverthless, the specific activity of the 
latter was comparable to that of rat testis crude nuclei, known to be 
particularly rich of  PARPs. Eight different human sera collected at the 
transfusional centre were assayed. Although the activity measured was 
very low, radioactivity incorporation, expressed as mUnits/mg protein, 
was comparable for all sera.  
 
TABLE 2 – ADP-ribosylating activity of HPBP and PARPSso 
Sample mU/ml mU/mg 
Rat testis nuclei
1
 14 ± 2.2 0.7 ± 0.25 
DNase supernatant
2
 4.5 ± 1.1 0.3 ± 0.07 
Human sera
3
 0.17 ± 0.06 0.009 ± 0.003 
PARPSso
4
 16.7 ± 4.0 42 ± 5.0 
HPBP
5
 0.25 ± 0.02 1.19 ± 0.07 
1Mean value (MV) of 6 nuclei preparations from different adult male rats, in 
duplicate. 2MV of three different DNase supernatants, in duplicate. 3MV of 8 
different human sera, in duplicate. 4MV of 3 preparations of purified PARPSso, in 
duplicate. 5Triplicate assay on a single HPBP preparation. 
 
As phosphate binding proteins, a presumable alkaline phosphatase 
activity was hypothesized for pure HPBP and PARPSso. Figure 12 shows 
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the results for this assay. Compared to HPBP, the rate of absorbance 
increase was about three fold higher for PARPSso. 
 
 
Figure 12: Reaction rates of PARPSso (A) and HPBP (B) 
phosphatase activity. 2 g enzyme/assay at 1 mM substrate. 
 
 
 
Table 3 shows the corresponding specific activities, in comparison with 
phosphatase activity determined for DING protein from Thermus 
thermophilus (Pantazaki et al., 2008). As a positive control commercial 
alkaline phosphatase from human placenta was used. The highest activity 
was measured for human placenta, close to that of Thermus enzyme. 
Much lower were the activities for HPBP and PARPSso.  
 
 
TABLE 3: Alkaline phosphatase activity of HPBP and PARPSso 
Sample  U/mg  
PARPSso*  1.75  
HPBP*  0.50  
Human placenta phosphatase* 53.0  
DING Phosphatase  
from T. thermophilus
 °°
 
54.0 
        *Mean value of a triplicate assay per sample; SD<5% ; 
        °°From Pantazaki et al., 2008. 
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3.2  Cell content and intracellular distribution of PARPSso 
Two main questions of the research on PARPSso raised: its  cellular 
content and its localization in intact cells. 
In the laboratory where this thesis work has been developed, biochemical 
and structural properties of PARPSso have been defined by analysing a 
pure protein purified from a crude homogenate. This sample, provided by 
the Fermentation service laboratory of ICMIB (CNR, Naples), was 
obtained from wet cells ground with glass beads and centrifugation as 
described in Faraone Mennella et al., 1995. As this procedure allowed to 
solubilize fairly 50% of the whole protein content, one objective of this 
thesis was to determine the exact amount and intracellular distribution of 
the thermozyme starting from a whole cell culture. 
 
 
3.2.1 Analysis of ADP-ribosylating activity in S. solfataricus cells at 
different growth phases 
S. solfataricus cells were grown on complex (yeast) and minimum 
(glucose) medium and collected at exponential and stationary growth 
phases. After removing the growth medium by centrifugation, the pelleted 
cells (1 O.D.600), have been resuspended as described in Materials and 
Methods (§ 2.2) and tested for ADP-ribosylating activity (Table 4). 
PARPSso activity was normalized to 1 O.D. 
 
 
TABLE 4: ADP-ribosylating activity of lysed sulfolobal 
cells grown on yeast (Y) or glucose (G) medium at  
exponential (E) and stationary (S) phases.  
 
 
 
 
 
 
 
 
 
 
 
 
  
The results indicate there is an inverse correlation between the growth 
phases and enzyme levels, with a decrease of enzyme activity from 
exponential phase to stationary one, for both Y and G media. These data 
CELLS mU (10-2)/ O.D.
600
 
CYE 3.5 ± 0.2 
CYS 2.0 ± 0.3 
  
CGE 3.8 ± 0.8 
CGS 2.9 ± 0.6 
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are in line with the reported ones for crude homogenate used in the past 
(Faraone Mennella et al., 1995).  
 
 
3.2.2 SDS-PAGE of sulfolobal cell lysates at different growth phases 
and extraction procedures 
The sulfolobal cells, grown on complex and minimun medium were 
analysed on SDS-PAGE. The Coomassie-stained gel shows similar 
protein heterogeneity in all samples, except for CYS, where some bands 
are missed (Figure 13A). Anti-PARP antibodies (Abs) gave a main 
immunopositivity (less evident in CYS sample) at about 70 kDa for all 
samples and very weak signals at about 40 kDa, expecially for CGS. 
Some signals at low molecular weights are in CYS (Figure 13B).  
 
 
 
Figure 13: Analysis of total lysate of S. solfatricus cells (C) grown on yeast (Y) 
and glucose (G) medium at exponential (E) and stationary (S)  growth phases. 
A) SDS-PAGE (12%), Coomassie staining;  B) Immunoblotting analysis with anti- 
PARP-CS Abs. 
 
 
Following this lysis procedure PARPSso was detected as a band at high 
molecular weight rather than as 46.5 kDa protein. In order to study 
whether this form might be an artifact of the lysis procedure, and might 
be reverted to the 46.5 kDa protein, various extraction procedures from a 
whole cell culture on yeast medium at stationary phase were performed. 
The different protocols considered the new structural finding that indicate 
PARPSso to be a DING protein, and that some other DING proteins are 
membrane bound.  
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Procedure 1 
The pelleted cells were resuspended in lysis buffer, sonicated and 
centrifuged to separate the first soluble fraction (FS) from pellet (P1). 
Two successive extractions of pellets (MM) produced a ”Fraction with 
Medium Solubility (FMS)” and an ”Insoluble fraction” (FI), obtained 
with detergent treatment. The residual pellet was called (P3). This 
procedure is usually applied to separate cytoplasmic proteins (FS) from 
extrinsic membrane proteins (FMS) and intrinsic proteins (FI). The final 
pellet (P3) contains insoluble, proteinaceous material. 
In Table 5 ADP-ribosylating activity values of PARPSso in the various 
extracts (L, FS, FMS, FI) and in the pellet (P3) are reported. 11% of total 
activity (16.4 mU) is in FS, FMS, FI; about 42% is still associated with 
pellet. The latter activity might be understimated as for pellet it was 
difficult to quantify enzyme content. 
  
 
TABLE 5: ADP-ribosylating activity of PARPSso in different 
fractions 
Fraction Tot mg  Tot mU mU/mg 
Lysate (L) 202 16.4 0.08 
FS 7.5 0.2 0.03 
FMS 10 0.6 0.06 
FI 18.8 1.0 0.05 
P3 n.d. 7.0 n.d. 
                                 The assays were performed in duplicate, with SD ≤ 5%. 
 
 
Protein extracts and pellet were analysed by SDS-PAGE followed by 
immunoblotting with anti PARP-CS Abs (Figure 14). Despite protein 
patterns are heterogeneous for all the extracts (FS, FMS, FI) and smearing 
in  pellet 3,  (Figure 14A), the immunosignal with anti-PARP-CS Abs is 
specific and is localized above the standard protein at 200 kDa; the signal 
is evident in L (lysate), very weak in FS and FMS, and more evident in 
FI. In line with activity results, most of the protein is still associated with 
the pellet, from low molecular weight to different aggregation forms 
(Figure 14B). 
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Figure 14: Analysis of protein extracts and pellet from procedure 1. 
L: lysate; FS: Soluble Fraction; FMS: Fraction with Medium Solubility; 
FI: Insoluble Fraction; P3: residual pellet. 
A) SDS-PAGE 12%, Coomassie staining. 
B) Immunoblotting with anti-PARP-CS Abs. 
 
 
These results indicate that the used extraction conditions produce 
probably an aggregated form of the enzyme, with respect to that present at 
about 70 kDa and observed in the analysis of the total cell lysate (Figure 
14B). Only in the pellet, P3, other different forms at lower MW can be 
detected (Figure 14B). 
 
Protein extraction from pellet 3  
The association of  most PARPSso activity with pellet demonstrates 
that also in the past the enzyme recovery was not complete as the starting 
homogenate was already lacking in insoluble component (cell debris), 
removed by initial centrifugation.  
In order to reduce the different immunosignals and to improve the recover 
from pellet 3, already derived from drastic extraction conditions, this 
fraction was divided in aliquots and treated, at 80 °C for 45 min, in the 
following conditions: 
1- 1% Triton X-100  
2- 1% SDS  
3- 1% NP-40  
4- 100 mM phosphate buffer, pH 7.5 
 
Immunoblotting analysis with anti PARP-CS Abs after SDS-PAGE and 
western blotting of the extracts and remaining pellets, shows that, despite 
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the coomassie stained profiles indicate the solubilization of a lot of 
proteins (data not shown), in all the extracts the immunopositive signal is 
very weak and mostly localized at standard high MW proteins level 
(Figure 15A). The strongest signals are still associated to pellets. It is 
interesting to note that with non ionic detergents (Triton X-100 and NP-
40) and phosphate buffer, there are more forms of the enzyme in the 
pellets, mainly the one at higher MW. Only SDS treatment seems to 
stabilize the form at about 70 kDa (Figure 15A). 
 
 
Figure 15: Analysis of the extracts (E) and remaining pellets (P) after 
treatment of the previous P3 in different conditions. 
1: 1% Triton X-100; 2: 1% SDS; 3: 1% NP-40; 4: 100 mM phosphate buffer, 
pH 7.5. A) Immunoblotting with anti-PARP-CS Abs. B) 0.7% Agarose gel. 
 
 
The analysis of the same samples on agarose gel indicates that in the 
pellet and in the extract after SDS treatment short fragments of DNA are 
present, compared to other pellets (P1, P2, P4) where DNA has larger size  
(Figure 15B). 
Considering that PARPSso interacts with endogenous DNA and that 
previously, enzyme solubilization was favoured by DNase digestion we 
performed a new protocol by adding DNase digestion step after lysis by 
sonication, and in the last step we utilized the best extraction, with 1% 
SDS, just tested before. 
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Procedure 2 
Table 6 reports the activity values detected in the fractions obtained 
with procedure 2.  
By comparing procedure 1 and 2,  DNase I digestion is able to solubilize 
most of thermozyme already in the first, most soluble fraction. In fact, 
50% is already present in FSDNase and a further 20% in FIDNase. The acid 
treatment utilized to have the FMSDNase is probable responsible of the low 
activity of this fraction. 
 
 
                    TABLE 6: ADP-ribosylating activity of PARPSso in different  
                     fractions after DNase digestion  
Fraction Tot mg  Tot mU  mU/mg 
Lysate (L)DNase 130 30 0.23 
FSDNase 100 15 0.15 
FMSDNase 12 1.56 0.13 
FIDNase 11 6.5 0.56 
P3DNase n.d. 5.8 n.d. 
       The assays were performed in duplicate, with SD ≤ 5%. 
 
 
 
The samples of Table 6 were analysed by SDS-PAGE and 
immunoblotting as described before. An immunopositive signal is 
distributed in all fractions, either at high or low solubility (Figure 16B). In 
the pellet P3 and in FIDNase it appears as a double band at about 70 kDa; 
some signals corresponding to aggregated forms are also present. 
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Figure 16: Analysis of protein extracts and pellet from procedure 2. 
 L: lysate; FS: Soluble Fraction; FMS: Fraction with Medium Solubility; 
FI: Insoluble Fraction; P3: residual pellet. 
A) SDS-PAGE 12%, Coomassie staining. 
B) Immunoblotting with anti-PARP-CS Abs. 
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Agarose gel electrophoresis of fractions from procedure 1 and 2 
In absence of DNase treatment (procedure 1), in the lysate the DNA 
is mostly intact, except for small fragments probably due to the sonication 
effect; in the pellet the pattern is comparable, whereas in the extracts 
small DNA fragments are present (Figure 17A). After DNase digestion 
(procedure 2), cell lysate show DNA fragments with different size 
distributed up to the gel region corresponding to low MW fragments 
(Figure 17B). In FSDNase smaller fragments are evident, whereas in 
FMSDNase the fluorescence signal cover a middle gel region. The FIDNase 
fraction is enriched in a band at about 1000 kbp, and in the pellet P3DNase 
there are DNA fragments with different sizes. 
 
 
 
 
Figure 17: 1% Agarose gel analysis of the extracts and pellet from 
procedure 1 and procedure 2 (+ DNase I digestion). 
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Pellet extraction with organic solvent 
The pellet P3DNase was subjected to butanolic extraction. The SDS-
PAGE and immunoblotting analysis indicate that the protein is present in 
the organic phase, water phase and interphase (Figure 18A). The presence 
of the protein also in the organic phase, to which correspond a weak 
protein pattern (data not shown), suggests a very selective extraction of 
the enzyme, probably in association with apolar components such as 
membrane lipid. The DNA content analysis shows the co-presence of the 
enzyme with DNA (Figure 18B).  
 
 
 
Figure 18: Analysis of fractions obtained from butanolic 
extraction of pellet P3DNase. 
B: butanolic phase; W: water phase; I: interphase; P: pellet 
A) Immunoblotting with anti-PARP-CS Abs. 
B) 1% Agarose gel. 
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3.3 Interaction of PARPSso  with DNA  
The results obtained from the new extraction approaches raised 
some new questions about intracellular localization of thermozyme. Its 
resistance to detergents and distribution in both aqueous and organic 
fractions allowed to hypothesize that PARPSso is probably interacting 
with membrane. On the other hand the enzyme had been found to bind 
DNA (Faraone Mennella et al., 2002), and, in the present study, 
sulfolobal DNA is associated with PARPSso almost in all fractions 
obtained with the new procedures. 
Therefore, further researches were addressed to get further evidences of 
PARPSso/DNA interaction and to explain the widespread distribution of 
DNA even in those fractions where PARPSso seems to be associated with 
membrane lipids, being soluble in organic solvent. 
Three experimental approaches were used: 1- PARPSso/DNA interaction 
was tested in sensible reconstitution experiments with purified PARPSso 
and fluorescent ss- and ds-oligonucleotides of different structures; 2- 
sulfolobal nucleoid was prepared by centrifugation of cell lysate on 
sucrose gradient; 3- fluorescent microscopy analysis was performed with 
intact cells to immunolocalize PARPSso intracellularly. 
 
 
3.3.1 Fluorescence binding assay 
In this study we used a sensitive fluorescence anisotropy method 
to characterize the interaction of PARPSso with different types of single 
and double stranded oligonucleotides. 
In these preliminary experiments the 5’-FAM labeled ssDNA 
oligonucleotide is 45 bp with low GC percent according to the sulfolobal 
genome characteristics. The addition of PARPSso led to an increase in 
fluorescence anisotropy (Figure 19A), and when data were fitted to a 
Ligand binding-1 site equation (Materials and Methods, § 2.9), yielded a 
dissociation equilibrium constant of 3.7 M. 
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Figure 19: Anisotropy curves for binding of PARPSso to DNA oligos. 
Fluorescence anisotropy was reported as Anisotropy values (A=A-A0; 
Materials and Methods § 2.9)   
Titration of PARPSso with 50 nM of A) 5’-FAM labeled single strand 
oligo: oligo ss-a; B) 5’-FAM labeled double strand oligo: oligo ds-b. 
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When fluorescence anisotropy titration with 50 nM “oligo ds-b” (Figure 
19B) was performed with PARPSso, we observed an high affinity binding 
to DNA corresponding to Kd value of 0.6 M, about 6 times lower than 
the previous one. This means that affinity of PARPSso for “oligo ds-b” is 
higher than that for  single strand oligos. 
No significant changes in anisotropy were observed when 50 nM of 
different dsDNA oligos (nicked and gapped dsDNA) were titrated with 
PARPSso (data not shown), indicating that, under the experimental 
conditions used,  no strong interaction occurs between these structures. 
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3.3.2 Nucleoid preparation 
In order to study PARPSso-DNA interaction with respect to own 
genomic DNA, the archaebacterial nucleoid from S. solfataricus cells was 
isolated. Suspension of cell lysate in 5% sucrose before layering onto 
sucrose gradient, allowed to avoid trapping of heavy material (chromatin) 
on the top of the gradient. DNA and protein content of the collected 
fractions were estimated  by monitoring absorbance at 260 and 280 nm 
respectively (figure 20A). The two profiles were almost overlapping, with 
high absorbance peaks corresponding to low percent of sucrose gradient, 
followed by an intermediate region with small peaks and an increase of 
absorbance towards the bottom of the gradient (Figure 20A). 
According to UV absorbance profiles, the fractions corresponding to low 
percent of sucrose gradient (top) are enriched of DNA, as revealed by 
their analysis on agarose gel (Figure 20B). At the top of the gradient     
(15-20% sucrose; fractions 1-8), DNA with higher electrophoretic 
mobility was localized, while at 45-50% sucrose, (fractions 28-35) the 
fluorescence signal was retained at the top of the gel (larger DNA), Figure 
20B. 
As revealed by immunoblotting with anti-PARP-CS antibodies, in the 
chromatin fractions at top PARPSso appeared also in the low molecular 
weight form at about 40 kDa, associated with high and medium mobility 
DNA (Figure 20C). 
In correspondence of low electrophoretic mobility DNA (towards the 
bottom of the gradient ), a main signal at about 70kDa was predominant 
(Figure 20C). 
In the fractions 14-27, corresponding to the middle gradient region, traces 
of  DNA (Figure 20B) and PARPSso (data not shown) were detectable.  
The specific association of DNA and thermozyme with both low (top) and 
high (bottom) sucrose gradient, but not in the middle of it, suggests a non 
random distribution of chromatin fractions that would be expected to 
localize only at the highest sucrose percent. 
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Figure 20: A) Sucrose gradient profile of nucleoid from S. solfataricus lysate. The  
1 ml fractions were analyzed for UV absorption, at 260nm (blu line) and at 280nm 
(red line);  B) 0.7% Agarose analysis of gradient fractions; C) Immunoblotting with 
anti-PARP-CS Abs of gradient fractions after SDS-PAGE 12%. 
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In order to understand whether and where the gradient fractions could 
contain membrane lipids, present in the cell lysate, we chose to analyse 
some fractions at different gradient percentage. Fractions 2, 5, 8, 10, 13, 
22, 32, 35 were separated on TLC and stained with amido Black. The 
blue color indicated the presence of lipids in all the analysed fractions 
(Figure 21). Lipids were expected to be present in the upper gradient 
fractions, because membranes, lighter than chromatin, are retained at low 
sucrose percent. As opposite it is rather unusual to find lipids associated 
with heavy chromatin at bottom of the gradient. 
 
 
 
 
Figure 21: Separation of some main gradient fractions via thin 
layer chromatography. Visualization of lipids was performed by 
using 0.5% amido Black; numbers correspond to the analyzed 
gradient fractions after lipid extraction procedure.  
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3.4 Intracellular localization of PARPSso  
In order to investigate the intracellular localization of  PARPSso 
and its relationship with cell components, we carried out fluorescence 
light microscopy experiments on S. solfataricus cells, fixed with 100% 
methanol, by using DNA staining with DAPI, membrane staining with 
FM64, and in parallel anti-PARP-CS antibodies. 
 
 
Figure 22:  Epifluorescence microphotographs of S. solfataricus cells.  
A) Phase contrast image; B) DAPI-stained DNA (blue); C) FM64 staining of 
cell membrane (red); D) Merged image of DAPI- and FM64-stained cells.  
 
 
 
The blue color of DNA is centered in the cell (Figure 22, panel B), 
whereas all around, along the edge of the cell the membrane is detected in 
red (Figure 22, panel C). The merged image of DAPI- and FM64-stained 
cells is shown in panel D of the same figure. 
The fluorescence detection with anti-PARP-CS Abs shows a distribution 
of the enzyme that outlines the perimeter of the cells (Figure 23). This 
first result is indicative of membrane localization of PARPSso. 
Human A375 melanoma cell line was used as positive control, and 
compared with the membrane staining by FM-64, the 
immunofluorescence with anti-PARP-CS antibody indicates PARP-1 
accumulates in the nucleus (Figure 24).  
Moreover, as a control of the specificity of the anti-PARP-CS antibody, 
we also verified the absence of detectable signal in E. coli cells (Figure 
24). 
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        S. solfataricus cells 
 
Figure 23: Immunolocalization of PARPSso in sulfolobal cells 
A) Phase contrast image; B) Localization of PARPSso with the specific 
anti-PARP-CS antibody: secondary antibody coupled to Alexa Fluor 
488 (green); C) Merge of a phase contrast image and an 
immunofluorescence image of S. solfataricus cells; D) Merge of stained 
membrane image (red) and the immunolocalization with anti-PARP-CS 
antibody (green).  
 
 
 
 
Results 
48 
 
 
 
   A375 cells 
 
 
   
   E. coli cells 
  
 
Figure 24: Immunofluorescence microscopy with anti-PARP-CS Abs 
in human A375 melanoma cells and E. coli cells.  
A375 cells: A) Phase contrast image; B) immunolocalization of PARP-1 
with the specific anti-PARP-CS antibody; secondary antibody coupled to 
Alexa Fluor 488 (green). C) merge of phase contrast image and 
immunofluorescence image. D) merge of FM64 stained membrane image 
(red) and  immunofluorescence signal.  
E. coli cells: E) Phase contrast image; F) immunofluorescence analysis 
with anti PARP-CS antibody. 
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4. DISCUSSION/CONCLUSIONS 
Since its discovery in S. solfataricus, PARPSso was object of  a 
hard criticism as the sulfolobal genome did not include any gene sequence 
corresponding to classic PARPs. Neverthless, biochemical, kinetic and 
immunological  data, together with characterization of reaction products  
allowed to define it as a PARP-like enzyme, although with specific 
features linked to its thermophilic nature.  
The partially sequenced thermozyme overlaps the sequences of a class of 
proteins rather different than PARPs, the DING proteins. It is worth 
noting that the present partial amino acid sequence of PARPSso (46.5 
kDa) matches that of HPBP (38 kDa), the human serum DING protein, 
whose sequence is now complete.  
In the present work, in order to understand the relationship between 
biochemical and structural data about PARPSso and to know whether its 
behaviour is general for DINGs, crossing immunochemical and enzymatic 
analyses were undertaken with both human and sulfolobal proteins.  
As a matter of  the fact, HPBP and PARPSso have been demonstrated to 
be able to cross react with polyclonal either PARP and DING antibodies, 
the latter directed against bacterial or eukaryotic DINGs.  
An hypothesis is that the antigenic ability of the two proteins towards 
anti-PARP catalytic site antibodies, may be a consequence of tertiary 
rather than primary structure similarity. Evidence raised by 
immunochemical results may be in line with this hypothesis. In fact, the 
main anti- PARP-CS immunosignal has a mobility relative to about 70 
kDa, corresponding to a faint band detected by silver staining in both 
proteins, suggesting that antibodies recognized a more structured 
conformation than the 40 kDa one (Figure 10B, lanes 1-4 ). 
It must be underlined that 40 kDa-larger precursors of HPBP have been 
described in literature, whereas a “dimeric” form of PARPSso is observed 
after some mechanical treatments (sonication) of sulfolobal  samples 
(crude extracts). The 46.5 kDa PARPSso often changes into 70 kDa form, 
that is very stable under different treatments (De Maio et al., 2010). 
The fact that polyclonal anti-PARP-CS recognize preferentially the 70 
kDa in both samples lets to hypothesize that a different epitope raises 
from dimerization of purified proteins with a higher antigenic ability. 
Anti-PfluDING antibodies recognize this band only in sera and sulfolobal 
extract, but they react preferentially with monomer of HPBP and 
PARPSso. Polyclonal anti-DING-N-terminal antibodies reveal only the 
monomers of the two purified proteins at about 40 kDa.  
Focusing on the purified proteins, and considering that the presence of 
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precursors and/or contaminants can be excluded on the basis of amino 
acid sequence studies (a single N-terminus detected, peptide maps 
overlapping), the different behaviours of anti-PARP and anti-DING 
polyclonal antibodies suggest that they recognize one of the possible 
protein conformations. 
As expected, monoclonal antibodies are rather specific for 38 kDa HPBP; 
with one of the two monoclonal antibodies, a weak signal for PARPSso at 
about 40 kDa is also evident.  
It is worth noting that both proteins reacts with anti-PAR antibodies. They 
are fully reactive with monomers of HPBP and PARPSso, indicating that 
both proteins are endogenously modified with  polymer. 
The reactivity towards anti-PAR Abs allows to draw an hypothesis about 
the different cross–reactivity of the other analysed antibodies. The 
dimeric form of the two proteins presumably masks the presence of poly-
ADP-ribose, since anti-PAR do not recognize the 70kDa band. On the 
other hand the presence of PAR might reduce the antigenicity of 
monomeric HPBP and PARPSso towards anti-PARP-CS and produce the 
weak response observed. 
Anti-human N-terminus and anti-PfluDING Abs have a high cross 
reactivity for both HPBP and PARPSso at 40 kDa, as they recognize 
common structural regions, that might be masked in the high molecular 
weight forms of proteins. The only dimeric “signal”, with anti-Pflu, is in 
serum, thus suggesting the presence of a DING precursor. 
These results clearly show that HPBP and PARPSso share a cross 
reactivity towards anti-DING, -PARP, -PAR antibodies, and beside the 
still partial amino acid sequence of PARPSso, both proteins possess 
similar if not identical epitopes allowing to be recognized by all 
antibodies in either one (~40 kDa) or the other (>40 kDa) isoform. 
Functionally, they work as both PARP and alkaline phosphatase, although 
at different extents. 
PARPSso exhibits both activities higher than HPBP, and functions 
preferentially as ADP-ribosylating enzyme, with a specific activity 35 
times that of HPBP. Phosphatase activity of PARPSso was only 3 times 
higher than HPBP, although for both HPBP and PARPSso it was very low 
as compared with Thermus and human placenta enzymes. 
 
A main question raised with this work is the localization of PARPSso 
within the cell. Its association with DNA was widely demonstrated in the 
past (Faraone Mennella et al., 2002) and here it has been confirmed by 
anisotropy measure with fluorescent oligonucleotides. The new evidence 
from nucleoid preparation and fluorescent microscopy is that PARPSso 
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interacts also with cell membrane. 
A very recent paper reports that in sulfolobal cells the exosome, a RNA-
processing protein complex, is membrane-bound, and that membrane is 
involved in the spatial organization of the nucleic acid (Roppelt et al., 
2010). Their results of nucleoid preparation and immunofluorescent 
microscopy are very similar to those we obtained from our experiments.  
As the exosome proteins, PARPSso is localized along the periphery of the 
cell and the immunofluorescence signal overlaps that of membrane 
staining. On this basis can PARPSso be considered exclusively the bridge 
element between DNA and the cell membrane? Some of the presented 
results suggest that sometimes the thermozyme is still anchored to the 
membrane after all DNA is removed. Does this mean that the enzyme 
might exhibit also another function different from regulating DNA 
metabolism/organization? Further study is needed to answer this question. 
In conclusion, what emerges from the present data is a common 
immunological and enzymatic behaviour of human and sulfolobal 
proteins. They have structural similarity, with a phosphate binding motif, 
that allows to predict the phosphatase activity, found at low, but 
comparable levels. What is difficult to explain is that they both seem to be 
structurally unrelated with the classic PARP family. 
This question needs specific phylogenetic studies that go beyond the aim 
of this work. However we attempted an arbitrary computational approach 
to get evidence of any, even small, correlation of PARPSso with PARP 
structure. 
From BLAST and Prosite research towards all data bases, the available 
PARPSso sequence, integrated for the lacking peptides with the 
corresponding ones of HPBP, gave alignments with other DINGs and 
phosphate-binding proteins, but not with PARPs or any ADP-ribosylating 
enzyme. Therefore, we restricted the search field by using key words 
related to typical PARP domain or corresponding to each known PARP 
(from PARP-1 to PARP-18). The results allowed to draw the scheme of 
Figure 9, suggesting that despite the low similarity of aligned peptides, all 
PARP sequence derived from BLAST are localized in a specific amino 
acid region of PARPSso, spanning from the amino acid 100 to 300. 
Moreover, ahead of this sequence, there is a correspondence of PARPSso 
with NAD binding sites of pyridinic dehydrogenases.  
A re-evaluation of these data will be done in next studies, taking into 
account the alignment casuality and performing a systematic phylogenetic 
study, calculating the distances on the basis of possibly occurred 
mutations and of further experimental data.  
Far from drawing definite conclusions we can hypothesize that DINGs 
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and PARPs originated as a single protein with different structural 
modules, that underwent different evolutive fates to produce in higher 
organisms two proteins structurally and functionally divergent. 
As a matter of fact, in Archaea, simple prokaryotes with a simple 
proteome, it is frequent that an enzyme can exhibit various activities. 
PARPSso shows to be a multifunctional enzyme with both PARP and 
DING properties. It is conceivable that during evolution, different 
modules developed: the DING one, in a structurally related, but probably 
functionally different protein (DING, HPBP), with a residual “trace” of 
PARP activity, whereas other module(s) in S. solfataricus  became the 
starting point to generate a different kind of enzyme, namely PARP. 
On this basis we feel to draw a bold hypothesis that the dichotomy of 
HPBP and PARPSso might be explainable as a product of a divergent 
evolution towards ortologue proteins. 
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